Investing.com -- German airline Lufthansa’s air freight division, reported on Friday an uptick in demand for pharmaceutical shipments to the United States. This surge is attributed to drugmakers accelerating their shipments in anticipation of potential import tariff increases.

In a statement, Lufthansa Cargo disclosed that several large pharmaceutical companies, which have production sites in Europe, are ramping up their production and hastening shipments to the U.S. This move is primarily driven by the looming threat of tariff increases on pharmaceutical products originating from the European Union.

Earlier in the week, corporate executives and logistics firms revealed that some drug manufacturers are taking the uncommon step of increasing the volume of medicines sent by air to the U.S. This strategy is being employed as a precautionary measure against potential tariff hikes.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.